Susceptibility Weighted Imaging Study Session

Program for Toronto 2008 Study Group Meeting


Monday, 5 May 2008, 18:30, Room 717A/B


Thank you, Siemens, Inc., for your support of this program.

18:30 Introduction
  - Introduce the Elected Members of the Study Section
- Their Terms, Our Purpose
- Summary of Applications of SWI
  Mark Haacke, Ph.D., The MRI Institute for Biomedical Research, Detroit, MI, USA
Technical Overview (10min): - What is susceptibility weighted imaging?
- What are the challenges open today?
  Jürgen Reichenbach, Ph.D.,University of Jena, Jena, Germany
Clinical Overview (10min): - How is SWI useful clinically?
- What is needed to make it better?
- Some pediatric examples
  Karen Tong, M.D., Loma Linda University Medical Center, Loma Linda, CA, USA
Invited speakers: Talks are 5 min with 5 min discussion
Technical Applications:  
  fMRI with SWI
  Markus Barth, Ph.D., Radboud University, Nijmegen, The Netherlands
  Removing Phase Artifacts
  Jaladhar Neelavalli, B.E., Wayne State University, Detroit, MI, USA
  Animal Imaging
  Seong-Gi Kim, Ph.D., University of Pittsburgh, Pittsburgh, PA, USA
  Susceptibility Weighted Phase Imaging
  Alexander Rauscher, Ph.D., M.Sc., UBC MRI Research Centre, Vancouver, BC, Canada
  Susceptibility Weighted Imaging (SWI) at Ultra High Magnetic Field Strengths
  Andreas Deistung, Dipl.Phys., Friedrich-Schiller University Jena, Jena, Germany
Clinical Applications:  
  Jonathan Grynspan (Canadian representative)
  Trauma and Tumors
  Vivek Sehgal (US representative), M.D., University of Chicago Medical Center, Chicago, IL, USA
  Venous Applications
  Masahiro Ida (Japanese representative), M.D., Tokyo Metropolitan Ebara Hospital, Toyko, Japan
  MS Applications
  Yulin Ge, M.D., NYU School of Medicine, New York, NY, USA
  SWI and Perfusion in Stroke
  Kohsuke Kudo, M.D., Ph.D., Hokkaido University Graduate School of Medicine, Hokkaido, Japan